- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +21 more
- Locations
-
- Technische Universität Dresden, NCT/UCC, Early Clinical Trial Unit Dresden, Germany
Clinical trial condition
Relapsed Diffuse Large B-cell Lymphoma (DLBCL)
Explore clinical trials studying Relapsed Diffuse Large B-cell Lymphoma (DLBCL). Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Relapsed Diffuse Large B-cell Lymphoma (DLBCL) trial results
Active, Not Recruiting
Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL
NCT07393204
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, Italy
Active, Not Recruiting
Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
NCT02570542
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up Only) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Consent and Follow up Only) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Consent and Follow Up Only) Montvale, New Jersey, United States